Myeloma Research News

November 15, 2019November 15, 2019

Adding Vorinostat to Revlimid Post-transplant Maintenance Therapy May Benefit Myeloma Patients, Phase 1 Trial Shows

This post was originally published on this siteThis post was originally published on this site Adding the lymphoma therapy vorinostat to Revlimid (lenalidomide) ... Read more

November 13, 2019November 13, 2019

CRISPR-edited T-cells Safely, Effectively Target Cancer Cells in Myeloma Patients, Early Phase 1 Data Suggests

Myeloma Research News

This post was originally published on this siteThis post was originally published on this site A new approach using genetically modified T-cells — ... Read more

November 11, 2019November 11, 2019

Nektar Launches First-in-Human Trial Testing NKTR-255 in Myeloma, Non-Hodgkin’s Lymphoma

Myeloma Research News

This post was originally published on this siteThis post was originally published on this site Nektar Therapeutics is launching a first-in-human Phase 1 ... Read more

November 8, 2019November 8, 2019

Bispecific Antibody in Phase 1 Multiple Myeloma Trial Named Orphan Drug by FDA, Teneobio Announces

Myeloma Research News

This post was originally published on this siteThis post was originally published on this site The U.S. Food and Drug Administration (FDA) has granted orphan ... Read more

November 6, 2019November 6, 2019

Use of Darzalez and Xpovio Expected to Increase Due to New Approvals, Spherix Survey Shows

Myeloma Research News

This post was originally published on this siteThis post was originally published on this site U.S. blood cancer specialists are aware of recent ... Read more

November 4, 2019November 4, 2019

Darzalex Combo Approved in Canada for Newly Diagnosed Myeloma Patients Ineligible for Transplant

Myeloma Research News

This post was originally published on this siteThis post was originally published on this site Health Canada has approved Darzalex (daratumumab), in combination with standard ... Read more

November 1, 2019November 1, 2019

Next Up for ‘Moving Mountains for Multiple Myeloma’ — Patagonia

Myeloma Research News

This post was originally published on this siteThis post was originally published on this site With the goal of encouraging the multiple myeloma community ... Read more

October 30, 2019October 30, 2019

CARsgen’s CT053 Receives RMAT Status from FDA for Multiple Myeloma Treatment

Myeloma Research News

This post was originally published on this siteThis post was originally published on this site The U.S. Food and Drug Administration (FDA) has ... Read more

October 28, 2019October 28, 2019

I-Mab Expands its Ongoing Myeloma Clinical Trials of MOR202 to China

Myeloma Research News

This post was originally published on this siteThis post was originally published on this site I-Mab Biopharma is expanding to mainland China its ... Read more

October 25, 2019October 25, 2019

CHMP Recommends Darzalex Triple Combo for Some Newly Diagnosed Multiple Myeloma Patients in EU

Myeloma Research News

This post was originally published on this siteThis post was originally published on this site The European Medicines Agency (EMA) has recommended that Darzalex (daratumumab) ... Read more